Moderna Faces Complaint To SEC Over Vax Patent Row
By Dean Seal · December 22, 2021, 6:25 PM EST
Oxfam America has filed a whistleblower complaint with the U.S. Securities and Exchange Commission that accuses Moderna of misleading shareholders about a fiery patent dispute over its widely distributed COVID-19 vaccine....
To view the full article, register now.